Clinical Trial

Anti-pigmenting Effect of a Routine of Facial Products in Subjects With Melasma

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 23, 2024 (before its estimated January 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This 6 month, comparative study assesses the benefit of a dermocosmetic regimen (Serum B3 + B3 retinol night cream) for 6 months compared to hydroquinone 4% (the gold standard in hyperpigmentation) followed by the dermocosmetic regimen for 3 months or the Kligman Trio for 3 months followed by the dermocosmetic regimen for 3 months in adult women with melasma on the face.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06516224
Lead Sponsor Cosmetique Active International
Conditions Melasma
Enrollment 150 participants
Start Date 2024-07-15
Primary Completion 2025-01-31 (estimated)
Study Completion 2025-01-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-23